BeStock  
Stocks › Biotechnology › ADMA

ADMA Biologics ADMA

US equityMarket cap rank #2453Biotechnology
$13.17 −$0.17 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.30 +0.99%
Open$13.26
Prev close$13.34
Day range$13.10 – $13.47
Volume2.45M
Market cap$2.92B
P/E (TTM)17.1
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings17.8x
CheapRich

Above its usual level · 69th percentile, 5-year average -18.6x

#1429 of 2993 stocks by PE (1 = cheapest)

Price / book6.9x
CheapRich

Around its usual level · 51st percentile, 5-year average 8.8x

#4705 of 5330 stocks by PB (1 = cheapest)

Price / sales5.8x
CheapRich

Around its usual level · 58th percentile, 5-year average 6.6x

#4086 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-753x-432x-110x211xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$13.05
Price vs. fair value+0.9%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.92 – 8.78 51% (pricier than usual) #4705 of 5330 (1 = cheapest)
PE 17.77 16.51 -18.60 69% (pricier than usual) #1429 of 2993 (1 = cheapest)
PS 5.85 5.16 6.59 58% (pricier than usual) #4086 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ADMA.

Sign in to join the discussion.

Scroll to Top